Hematologist
CION Cancer Clinics
Lower-risk MDS: supportive care and monitoring | CION Cancer Clinics
Lower-risk MDS is usually treated with regular blood tests, red cell transfusions when needed, and medicines that help the marrow make more red cells. The aim is to ease symptoms and keep counts at a level you can live well with. This page explains the usual steps, who each option does and does not suit, and what the page cannot decide for you. At CION Cancer Clinics, every leukaemia, MDS and MPN case is reviewed by our haematologist and discussed at a tumour board before a plan is agreed.
BP
Medically reviewed by Dr. Basudev PokhrelConsultant Haematologist · last reviewed September 2026, next review due September 2027
17+specialists on panel
15,000+patients treated
35+centres across Telangana & AP
4.8★ / 800+Google rating
On this page
- How is lower-risk MDS treated?
- What does treatment usually look like, step by step?
- Which option suits whom, and who does it not suit?
- What is checked at your follow-up visits?
- What do families often believe about lower-risk MDS treatment?
- What can this page not tell you about your own treatment?
- Common questions about lower-risk MDS treatment
The short answer
How is lower-risk MDS treated?
Lower-risk MDS is usually treated with regular blood tests, blood transfusions when needed, and medicines that help the marrow make more red cells. The aim is to ease symptoms and keep your counts at a level you can live well with, rather than to wipe out the disease.
What lower-risk means
Your haematologist uses a risk score, most often the IPSS-R, built from your blood counts, marrow blasts and chromosome results. A very low, low or sometimes intermediate score usually counts as lower-risk. This kind of MDS tends to change slowly, often over years.
Why the plan is gentler
Strong treatments carry real side effects. When the disease is moving slowly, those side effects can do more harm than the disease itself. So the plan starts with the lightest step that controls your symptoms, and moves up only when it has to.
Who this approach does not suit
It is not the right plan if your score is high, if blasts are rising, or if counts are falling fast. It may also change for a younger, fit person whose gene results point to faster disease. In those cases treatment aimed at the disease itself, and sometimes a transplant, is discussed earlier.
The usual pathway
What does treatment usually look like, step by step?
-
Watching and waiting
If your counts are only mildly low and you feel well, you may need no treatment at first. Blood tests are repeated at intervals your haematologist sets, to catch any change early.
-
Support when the haemoglobin falls
When tiredness or breathlessness start to limit daily life, red cell transfusions are given. How often depends on your symptoms and counts, not on a fixed number.
-
Medicines that help make red cells
Injections of erythropoietin, a hormone that tells the marrow to make red cells, suit some people. Others may be offered luspatercept. Both aim to reduce the need for transfusions.
-
Treatment for specific types
MDS with a missing piece of chromosome 5, called del(5q), often responds to a tablet called lenalidomide. A small group with a very empty marrow may be offered medicines that calm the immune system.
-
Managing iron from transfusions
Many transfusions over time can build up iron in the body. Your team checks for this and may suggest medicines that remove the extra iron.
Not sure whether this applies to you?
Ask an oncologistThe main options
Which option suits whom, and who does it not suit?
Each option helps a particular group. Knowing who it does not help is as useful as knowing who it does.
Red cell transfusions
Suit almost everyone whose low haemoglobin causes symptoms. They work within hours but wear off, so they are repeated.
Less suited to
- People who already have high iron and cannot take iron-removing medicines
Erythropoietin injections
Work best when your own erythropoietin level is low and transfusion needs are still small. A blood test checks this before starting.
Less suited to
- People already needing frequent transfusions
- People with a high natural erythropoietin level
Luspatercept
Helps the late stages of red cell making. It is often considered when erythropoietin has not worked, especially in MDS with ring sideroblasts.
Lenalidomide
Used mainly for MDS with del(5q). It lowers platelet and white cell counts for a time, so blood tests are frequent at the start.
It must not be taken in pregnancy. Your team will explain the precautions.Regular follow-up
What is checked at your follow-up visits?
- A full blood count to track haemoglobin, platelets and white cells
- How tired or breathless you have felt since the last visit
- Any infections, fevers, bruising or bleeding
- Ferritin, a blood test that reflects iron stores
- Kidney and liver tests when you are on certain medicines
- A repeat marrow test if counts change without a clear reason
Leave a number, we will call you
One field. No form to fill in, and no charge for the call.
!
When not to wait for the next visit
A fever or shivering, bleeding that does not stop, black stools, sudden breathlessness, chest pain or confusion need care the same day. Go to the nearest emergency department or call 108, and tell them about the MDS and your latest counts. Do not wait to see whether it settles at home.
Commonly believed
What do families often believe about lower-risk MDS treatment?
"Only blood tests? The doctor is not really treating her."
Careful watching is a real treatment decision. It avoids side effects from medicines that would not help yet, and it catches any change early. The plan moves up when your counts or symptoms call for it.
"More blood transfusions will make the marrow lazy."
Transfusions do not stop your marrow working. They replace cells the marrow cannot make well enough. The real long-term concern is iron building up, which your team checks for.
"We should take iron tablets because the haemoglobin is low."
In MDS, low haemoglobin is rarely caused by low iron. Extra iron can add to the load from transfusions. Only take iron if your haematologist has checked your levels and advised it.
"If the injections stop working, there is nothing left."
Response to one medicine often fades with time. Other options exist, and transfusions remain available. Your haematologist will look at why it stopped working, which sometimes means repeating the marrow test.
Being straight with you
What can this page not tell you about your own treatment?
This page cannot tell you which option is right for you, or when to start it. That depends on your exact type of MDS, your score, your gene results, your other health conditions and what matters most to you.
Never change the plan on your own
Do not start, stop or skip an injection, tablet, transfusion or iron-removing medicine without speaking to your treating team. Even when you feel better, the counts may say something different.
What to bring and ask
Bring every blood report in date order, your marrow and chromosome reports, and a list of all medicines, including tonics and herbal ones. Ask what the goal of each treatment is, how you will know if it is working, and what the next step would be if it does not. At CION the haematology team reviews the case and presents it at a tumour board, and coordinates any test or treatment done at another centre.
Evidence for some newer options is still growing. Ask how much is known about the one being offered to you.Questions we are asked
Common questions about lower-risk MDS treatment
How often will blood tests be needed?
It depends on how stable your counts are and which treatment you are on. When things are steady, tests are spaced further apart. When a new medicine starts, or counts are falling, they are closer together. Your haematologist will set a schedule and change it as things change.
Can lower-risk MDS become higher-risk?
It can, though many people stay lower-risk for a long time. Faster falls in counts, rising transfusion needs or blasts in the blood can be signs. Regular follow-up exists to spot this. If it happens, the plan is reviewed and stronger treatment may be discussed.
Will I need a bone marrow transplant?
Most people with lower-risk MDS do not. A transplant carries serious risks, so it is usually kept for higher-risk disease or for lower-risk MDS that is worsening in a younger, fit person. CION does not perform transplants but can coordinate referral to a qualified centre if one is recommended.
Are the injections given at home?
Some injections given under the skin can be given at home after training, or at a nearby clinic. Others are given at the hospital. Your team will explain how and where your medicine is given, and what to watch for between visits.
What side effects should we expect?
It varies by medicine. Erythropoietin may raise blood pressure. Luspatercept can cause tiredness, joint aches or loose motions. Lenalidomide lowers platelet and white cell counts for a while. Report any new symptom to your team rather than stopping the medicine yourself.
Can my father keep working or travelling?
Many people with lower-risk MDS carry on with work and family life. Energy levels may shape the day, especially before a transfusion is due. For travel, carry recent reports and plan around blood tests. Ask your haematologist before long trips if counts are low.
Does diet help raise the counts?
A balanced diet helps you cope and keeps you stronger. It cannot fix the marrow or replace treatment. Avoid iron tablets, herbal tonics and supplements unless your haematologist agrees, because some add to iron load or interfere with blood tests and medicines.
Is treatment covered by Aarogyasri or insurance?
Parts of care may be covered by Aarogyasri, CGHS, ECHS, EHS, PM-JAY or cashless insurance when part of an approved plan. Coverage for some newer medicines varies, and scheme rules change. Call the helpline with your card details to check your current cover.
Your Haematologist
Meet CION's haematologist. One specialist for your blood report and your plan.
Dr. Basudev Pokhrel reviews blood counts, transfusion needs and blood disorders, and works with the CION tumour board on blood cancers.
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Sources
- American Cancer Society — Treating myelodysplastic syndromes
- National Cancer Institute — Myelodysplastic Syndromes Treatment (PDQ), Patient Version
- Leukemia & Lymphoma Society — Myelodysplastic syndromes
- Cancer.Net — Myelodysplastic syndromes (MDS)
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.
Keep reading
Related pages
Talk to us
Told your MDS is lower-risk?
Tell us what has been found so far. The haematology team will go through the reports and the plan with you. One helpline serves every CION centre.